50 N.J.R. 1704(a)
VOLUME 50, ISSUE 15, AUGUST 6, 2018
50 N.J.R. 1704(a)
NJ - New Jersey Register >
AUGUST 6, 2018 >
RULE PROPOSALS >
LAW AND PUBLIC SAFETY -- DIVISION OF CONSUMER AFFAIRS
Interested Persons Statement
Interested persons may submit comments, information or arguments concerning any of the rule proposals in this issue until the date indicated in the proposal. Submissions and any inquiries about submissions should be addressed to the agency officer specified for a particular proposal.
The required minimum period for comment concerning a proposal is 30 days. A proposing agency may extend the 30-day comment period to accommodate public hearings or to elicit greater public response to a proposed new rule or amendment. Most notices of proposal include a 60-day comment period, in order to qualify the notice for an exception to the rulemaking calendar requirements of N.J.S.A. 52:14B-3. An extended comment deadline will be noted in the heading of a proposal or appear in a subsequent notice in the Register.
At the close of the period for comments, the proposing agency may thereafter adopt a proposal, without change, or with changes not in violation of the rulemaking procedures at N.J.A.C. 1:30-6.3. The adoption becomes effective upon publication in the Register of a notice of adoption, unless otherwise indicated in the adoption notice. Promulgation in the New Jersey Register establishes a new or amended rule as an official part of the New Jersey Administrative Code.
LAW AND PUBLIC SAFETY > DIVISION OF CONSUMER AFFAIRS
Administrative Code Citation
Proposed Amendments: N.J.A.C. 13:45J-1.1, 1.2, and 1.4
Limitations on and Obligations Associated with Prescriber Acceptance of Compensation from Pharmaceutical Manufacturers
Authorized By: Gurbir S. Grewal, Attorney General.
Authority: N.J.S.A. 45:1-17.b.
Calendar Reference: See Summary below for explanation of exception to calendar requirement.
Submit written comments by
October 5, 2018, to:
Maryann Sheehan, Director, Legislative and Regulatory Affairs
Division of Consumer Affairs
124 Halsey Street, 7th Floor
PO Box 45027
Newark, New Jersey 07101
The agency proposal follows:
The Attorney General is proposing amendments to N.J.A.C. 13:45J, concerning limitations on, and obligations associated with, the acceptance of compensation from pharmaceutical manufacturers. Effective January 16, 2018, the former Attorney General enacted new rules at N.J.A.C. 13:45J to ensure that patient care is guided by the unbiased, best judgment of the treating prescriber. See 50 N.J.R. 578(a) The rules imposed a limitation of $ 15.00 on the amount of a modest meal that could be provided at an education event or promotional activity. Since the enactment of these rules, many have expressed concern about the impact of the modest meals limitation on the availability of venues conducive to a learning environment. In response to these comments, the Attorney General proposes to amend the modest meal limitation to distinguish between the amount allowable for breakfast and lunch, and that for dinner; provide a mechanism for adjusting these amounts; specify that the limitation does not include the cost of standard delivery, service, or facility rental fee charges, or tax; and to specify that meals associated with education events are not subject to the modest meal limitation. The Attorney General recognizes the educational value of learning about disease states and treatment options and believes that the proposed amendments will enhance the rules to further the educational exchange between practitioners and pharmaceutical manufacturers for the benefit of patient care.
The proposed amendments at N.J.A.C. 13:45J-1.1 specify that the rules at N.J.A.C. 13:45J apply to a prescriber (physician, podiatrist, physician assistant, advanced practice nurse, dentist, or optometrist) who holds an active New Jersey license and who either practices in New Jersey or has New Jersey patients, regardless of the prescriber's practice site. The heading of this section is also proposed for amendment to reflect that the rule encompasses the scope of the rules.
The Attorney General proposes to amend the definitions at N.J.A.C. 13:45J-1.2 of the terms "modest meals," and "prescriber," and to include a definition for "Consumer Price Index." The proposed new term "Consumer Price Index" is defined as the annual average, rounded to the nearest dollar, of the Consumer Price Index for Food Away From Home-Northeast Urban, as posted in January for the preceding year by the U.S. Department of Labor Bureau of Labor Statistics at
http://www.bls.gov/, or a successor index. To round, amounts under 50 cents shall be disregarded, and amounts of 50 cents or more shall be increased to the next dollar.
The proposed amendments to "modest meals" specify that the fair market value limitation in the calendar year 2018 is $ 15.00 for breakfast or lunch, and $ 30.00 for dinner. In addition, the Attorney General is proposing to include a mechanism to adjust these dollar amounts based upon changes in the Consumer Price Index. If the Consumer Price Index increases by 50 cents or more, the specified amounts allowed for modest meals will be increased to the next dollar. The proposed amendments also make it clear that the fair market value does not include the cost of standard delivery, service, or facility rental fee charges, or of tax.
The proposed amendment to the term "prescriber" specifies that the rules apply to only those physicians, podiatrists, physician assistants, advanced practice nurses, dentists, or optometrists who have an active New Jersey license. This proposed amendment is consistent with the proposed clarification that the rules at N.J.A.C. 13:45J apply to those prescribers who practice in New Jersey or who have patients in New Jersey.
As noted above, the Attorney General recognizes the value of education and believes that prescribers may benefit from educational programs that are offered by pharmaceutical manufacturers and that the information enhances patient care. Accordingly, the proposed amendments to N.J.A.C. 13:45J-1.4 remove any limitation on the value of meals provided through the event organizer at an education event, even if supported by a manufacturer, as long as the meals facilitate the educational program to maximize prescriber learning, including information about disease states and treatment approaches. Meals provided by a pharmaceutical manufacturer to non-faculty prescribers through promotional activities will remain subject to the modest meal limitations.
The Attorney General also proposes to amend N.J.A.C. 13:45J-1.4(a)3 and 4 to specify that meals provided through the event organizer at an education event and the modest meals provided by a pharmaceutical manufacturer to non-faculty prescribers through promotional activities are not subject to the bona fide services cap set forth at N.J.A.C. 13:45J-1.6.
The Attorney General has determined that the comment period for this notice of proposal shall be 60 days; therefore, pursuant to N.J.A.C. 1:30-3.3(a)5, this notice is excepted from the rulemaking calendar requirement.
The proposed amendments will have a positive social impact on prescribers and patients. The proposed amendments will permit the types of venues that are conducive to a learning environment to be used for education events, which will ensure that prescribers can participate in learning opportunities to enhance patient care.
The proposed amendments will not have an economic impact on prescribers or patients. The proposed amendments may have a positive economic impact on the restaurant industry, its suppliers, and employees.
Federal Standards Statement
A Federal standards analysis is not required because the proposed amendments are governed by N.J.S.A. 45:1-17.b and are not subject to any Federal standards or requirements.
The proposed amendments will not result in an increase or decrease in the number of jobs in the State.
Agriculture Industry Impact
The proposed amendments will have no impact on the agriculture industry in the State.
Regulatory Flexibility Statement
Currently, the Division of Consumer Affairs licenses 62,500 prescribers. If these are considered "small businesses" within the meaning of the Regulatory Flexibility Act, N.J.S.A. 52:14B-16 et seq., then the following analysis applies.
The proposed amendments do not impose any recordkeeping, compliance, or reporting requirements upon licensees, and no additional professional services will be needed to comply with the proposed amendments. The costs of compliance with the proposed amendments are discussed in the Economic Impact statement above. The Attorney General believes that the proposed amendments should be uniformly applied to all licensees in order to ensure the welfare of the general [page=1705] public in the provision of healthcare services. Therefore, no differing compliance requirements for any licensees are provided based on the size of the business.
Housing Affordability Impact Analysis
The proposed amendments will have an insignificant impact on the affordability of housing in New Jersey, and there is an extreme unlikelihood that the proposed amendments would evoke a change in the average costs associated with housing because the proposed amendments concern limitations on and obligations of prescribers associated with the acceptance of compensation from pharmaceutical manufacturers.
Smart Growth Development Impact Analysis
The proposed amendments will have an insignificant impact on smart growth and there is an extreme unlikelihood that the proposed amendments would evoke a change in housing production in Planning Areas 1 or 2, or within designated centers, under the State Development and Redevelopment Plan in New Jersey because the proposed amendments concern limitations on and obligations of prescribers associated with the acceptance of compensation from pharmaceutical manufacturers.
Racial and Ethnic Community Criminal Justice and Public Safety Impact
The Attorney General has evaluated this rulemaking and determined that it will not have an impact on pretrial detention, sentencing, probation, or parole policies concerning adults and juveniles in the State. Accordingly, no further analysis is required.
Full text of the proposal follows (additions indicated in boldface
thus; deletions indicated in brackets [thus]):
SUBCHAPTER 1. LIMITATIONS ON AND OBLIGATIONS ASSOCIATED WITH PRESCRIBER ACCEPTANCE OF COMPENSATION FROM PHARMACEUTICAL MANUFACTURERS
(a) The rules in this chapter regulate the receipt and acceptance by prescribers of anything of value from pharmaceutical manufacturers to ensure that such relationships do not interfere with prescribers' independent professional judgment.
(b)The rules in this chapter shall apply to a prescriber who holds an active New Jersey license and who:
1. Practices in New Jersey; or
2. Has New Jersey patients regardless of the prescriber's practice site.
The following words and terms when used in this chapter shall have the following meanings, unless the context clearly indicates otherwise:
. . .
"Consumer Price Index" means the annual average, rounded to the nearest dollar, of the Consumer Price Index for Food Away From Home--Northeast Urban, as posted in January for the preceding year by the U.S. Department of Labor Bureau of Labor Statistics at
or a successor index. To round, amounts under 50 cents shall be disregarded, and amounts of 50 cents or more shall be increased to the next dollar.
. . .
"Modest meals" means a food and/or refreshment, where its fair market value does not exceed $ 15.00
(for breakfast or lunch) or $ 30.00 (for dinner), in 2018, for each prescriber.
In each succeeding calendar year after 2018, these amounts shall be adjusted if the Consumer Price Index reflects a sum, which, if rounded, consistent with the definition of "Consumer Price Index," would raise it by one dollar increments. The fair market value shall not include the cost of standard delivery, service, or facility rental fee charges, or of tax.
. . .
"Prescriber" means a physician, podiatrist, physician assistant, advanced practice nurse, dentist, or optometrist [licensed]
who has an active license pursuant to Title 45 of the Revised Statutes. "Prescriber" does not include a licensee who is an employee, as defined in N.J.A.C. 18:35-7.1, of a pharmaceutical manufacturer who does not provide patient care.
. . .
13:45J-1.4 Permitted gifts and payments
(a) Consistent with the requirements of this chapter, a prescriber may accept the following from a pharmaceutical manufacturer or manufacturer's agent:
1.-2. (No change.)
3. [Modest meals]
Meals provided through the event organizer at an education event,
even if supported by a manufacturer, provided the meals facilitate the educational program to maximize prescriber learning, including information about disease states and treatment approaches.
Meals in this context are not subject to the limitations set forth in the definition of "modest meals," nor are they subject to the bona fide services cap set forth at N.J.A.C. 13:45J-1.6.
4. Modest meals provided by a manufacturer to non-faculty prescribers through promotional activities.
Modest meals in this context are not subject to the bona fide services cap set forth at N.J.A.C. 13:45J-1.6.
5.-10. (No change.)
In order to ensure your comments are received, please send your comments concerning any rule proposals via email to DCAProposal@dca.lps.state.nj.us.
Please include the following in your email:
Email Subject Line: Rule Proposal Subject
Email Body: Comments to the Rule Proposal, Name, Affiliation and Contact Information (email address and telephone number)